Specific germline mutations in POLD1 and POLE have recently been shown to cause multiple colorectal and endometrial tumours in affected individuals23, 24, and the mutation in MSH2 is consistent with the observation that MMR gene mutations are enriched in high-grade prostate cancers25. Here, POLD1 is linked to endometrium neoplasm.